Eledon Pharmaceuticals

About Eledon Pharmaceuticals

Eledon Pharmaceuticals, Inc. is dedicated to the mission of 'One Transplant for Life,' aiming to improve the longevity of transplanted organs and the overall health and quality of life for transplant recipients. The company is committed to ensuring that a donor's greatest gift continues to benefit recipients through innovative immunomodulatory therapies.

Products & Services

Tegoprubart:An anti-CD40L antibody with broad therapeutic potential to regulate immune responses that lead to organ rejection. It is currently in clinical trials for preventing rejection in kidney transplant recipients and is being evaluated for other types of organ transplantation, including liver transplantation and xenotransplantation.

Specialties

Immunomodulatory therapy Organ transplantation Anti-CD40L antibody development Xenotransplantation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2025-11-12 FD: 2025-11-12	3 investors
2	RT: Private Placement T: - FT: Private Placement	A: 50000000 MR: - FA: approximately $50 million FAN: 50000000	D: 2024-05-07 FD: 2024-05-07	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 185000000 MR: - FA: up to $185 million FAN: 185000000	D: 2023-05-01 FD: 2023-05-01	3 investors

Underwritten Public Offering Latest

2025-11-12

$50.0M

3 investors (Pro only)

Private Placement 2024-05-07

$50.0M

Private Placement 2023-05-01

$185.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David-Alexandre C. Gros

Chief Executive Officer and Board Member

S

Steven Perrin

President and Chief Scientific Officer

M

Marina Escudero

Vice President and Head of Clinical Operations

J

John Herberger

Vice President, Technical Operations

D

David Hovland

Chief Regulatory Officer

E

Eliezer Katz

MD, FACS

View 13 more team members with Pro

Unlock Full Team Directory

Recent News